Product 1

Welcome to our web-presentation of

K-BIO Institute for Cellbiotechnology and Immunology GmbH

AUTOLOGOUS CANCER VACCINE AHICE, for Cancer After-Care, against Auto-Immune Diseases, and for prevention.

Autologous cancer vaccine AHICE is advantageous because of the absence of  allergic reactions and carry no risks of viral infection, like Hepatitis B or C or HIV (AIDS), etc..  

On the other hand, clinical studies have shown that the autologous cancer vaccine AHICE can successfully fight human pathogenic viruses - for example, successful elimination of HPV cervical infections, which otherwise lead to cervical cancer - testify to the extraordinary effectiveness of the autologous vaccine AHICE.

Autologous cancer vaccine AHICE, is distinguished by its unique target cell specificity and selectivity against cancer- and metastatic-cells.

Explanation, Notice:

Normally, the recognition of cancer cells in vivo by autologous immune system is not possible, because of “escape mechanisms intelligence” of cancer cell DNA (⇒ "masking" or disguise of cell shape to escape any attack from outside, e.g. autologous immune system).

AHICE´s KEY POINT

It is therefore absolutely necessary that the "masking" of  cancer cell´s surface is previously being removed / cleaved, to make them"recognisable" by autologous immune system.

Only after this AHICE pre-treatment of isolated cancer cells, body´s own immune system became able to recognise these cancer cells as differentiated pathologically.

This means, that patient’s own immune system will get specific informations of the altered shape(⇒ called morphology ⇒ μορφολογια ⇒ Greek) of cancer cells through AHICE´s special processing(patent).

Studies have shown that this specific “antigen information” is stored in the CD45RO+ lymphocytes.

However, this antigen information is deleted / disappears due to the immunosuppressive effects of analgesics, anti-inflammatory drugs, corticoids, cytostatics and cell destruction by the action of high-energy rays!

After autologous cancer vaccine AHICE´s application, body´s immune system starts to kill the so identified cancer cells via antigen specific activation of natural killer cells(NKC´s) and very complex mechanism of programmed cell death, called “apoptosis”, as the

unique intelligent, physiological “antigen-searching and selectively eliminating pharmacon (⇒ medicine)”.

This is a brief explanation of the indescribably complex immune response, which is unique intelligent directed, autonomous and auto-regulating itself, dependent on [kind] and [amount] of identified antigen, highly specific  biochemical / immunological mechanism.

Autologous Cancer Vaccine, Immunotreatment AHICE. Benefits

♦ Highly target cell specificity, provided via the unique “selectivity, detection and apoptotic elimination ability against the recognised antigens of cancer cells, reached by complete “antigen specific” immune-stimulation and attack of patient’s own immune-system.

♦ There are none side effects recorded, because of the autologous production of AHICE.

♦ The in vivo Effectiveness is proved in multicentric clinical trials until now at several carcinomata.

♦ Autologous cancer immunotherapy, autologous cancer vaccine AHICE is applicable on various carcinoma-kinds and -stages (exceptions: leukaemiae / lymphomas).

♦ Autologous cancer immunotherapy AHICE can applied also in combination with the conservative tumourtherapy (e.g. radiation- and/or chemotherapy) theoretically, but, it must be emphasised, that the therapeutic effect occurred, may depend upon the high level of suppression of immune system, derived on duration and strength of applied chemotherapy or/and radiation, as this negative effect is very well known. This combination of treatments is therefore contraindicated and not recommended.

♦ Special preparations of immunological blood treatment AHICE against  auto-immune diseases have recorded remarkable results therapeutically also at:

rheumatoid-arthritis, Hashimoto Thyreoiditis, auto-thrombocytopenie, Morbus Waldenström, MS, Morbus Crohn, Colitis Ulcerosa and other auto-immune-diseases (clinical trials by named oncological departments of universities).

K-BIO Institute is searching in Immunology/Biochemistry/Cell-Biology/Radio-Biology and is willing to co-operate scientifically with appropriate medicinal institutions, for broader statistical verification of the remarkable clinical AHICE treatment results.

Furthermore Informations → contact

next → Investors

next → CEO Researcher

next → medularythyroidcancer

next → AutoImmuneDiseases

next → MorbusWaldenstroem

next → peritoneal cancer

next → prostate cancer

next → morbus crohn

back → Home, Language